BCM
TYRA icon

Boxer Capital Management’s Tyra Biosciences TYRA Stock Holding History

Boxer Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,027,678
Closed -$28.2M – 58
2024
Q4 		$28.2M Buy
+2,027,678
New +$36.8M 2.4% 10

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Boxer Capital Management's TYRA Position: Q1 2025 in Review

Boxer Capital Management sold out of Tyra Biosciences (TYRA) in Q1 2025, closing a stake of 2,027,678 shares — an estimated $28.2M sold.

Boxer Capital Management first reported a position in TYRA in Q4 2024 and held it in 1 quarter. The position peaked at $28.2M in Q4 2024. 117 funds tracked by Wall St. Rank hold TYRA as of Q1 2025.

  • Boxer Capital Management reported no remaining Tyra Biosciences position as of Q1 2025 after selling out during the quarter.
  • Boxer Capital Management sold 2,027,678 Tyra Biosciences shares in Q1 2025, an estimated $28.2M.
  • Boxer Capital Management first reported a position in Tyra Biosciences in Q4 2024 and held it in 1 quarter.
  • Boxer Capital Management's Tyra Biosciences position peaked at $28.2M in Q4 2024.
  • 117 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2025.

Based on Boxer Capital Management's 13F filing for Q1 2025, filed 15 May 2025.